BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patra U, Mukhopadhyay U, Sarkar R, Mukherjee A, Chawla-Sarkar M. RA-839, a selective agonist of Nrf2/ARE pathway, exerts potent anti-rotaviral efficacy in vitro. Antiviral Res 2019;161:53-62. [PMID: 30465784 DOI: 10.1016/j.antiviral.2018.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Chandra P, Banerjee S, Saha P, Chawla-sarkar M, Patra U. Sneaking into the viral safe-houses: Implications of host components in regulating integrity and dynamics of rotaviral replication factories. Front Cell Infect Microbiol 2022;12:977799. [DOI: 10.3389/fcimb.2022.977799] [Reference Citation Analysis]
2 Banerjee S, Sarkar R, Mukherjee A, Miyoshi S, Kitahara K, Halder P, Koley H, Chawla-sarkar M. Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway. Front Microbiol 2022;13:951716. [DOI: 10.3389/fmicb.2022.951716] [Reference Citation Analysis]
3 Bhuinya A, Dass D, Banerjee A, Mukherjee A. A Tale of Antiviral Counterattacks in Rotavirus Infection. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.127046] [Reference Citation Analysis]
4 Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS. Nrf2/Keap1/ARE signaling: Towards specific regulation. Life Sci 2021;:120111. [PMID: 34732330 DOI: 10.1016/j.lfs.2021.120111] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 23.0] [Reference Citation Analysis]
5 Herengt A, Thyrsted J, Holm CK. NRF2 in Viral Infection. Antioxidants (Basel) 2021;10:1491. [PMID: 34573123 DOI: 10.3390/antiox10091491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cava C, Bertoli G, Castiglioni I. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation. Future Virol 2021. [PMID: 34306168 DOI: 10.2217/fvl-2020-0392] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Tohmé MJ, Delgui LR. Advances in the Development of Antiviral Compounds for Rotavirus Infections. mBio 2021;12:e00111-21. [PMID: 33975930 DOI: 10.1128/mBio.00111-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sander WJ, Fourie C, Sabiu S, O'Neill FH, Pohl CH, O'Neill HG. Reactive oxygen species as potential antiviral targets. Rev Med Virol 2021. [PMID: 33949029 DOI: 10.1002/rmv.2240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Patra U, Mukhopadhyay U, Mukherjee A, Dutta S, Chawla-Sarkar M. Treading a HOSTile path: Mapping the dynamic landscape of host cell-rotavirus interactions to explore novel host-directed curative dimensions. Virulence 2021;12:1022-62. [PMID: 33818275 DOI: 10.1080/21505594.2021.1903198] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 He F, Antonucci L, Karin M. NRF2 as a regulator of cell metabolism and inflammation in cancer. Carcinogenesis 2020;41:405-16. [PMID: 32347301 DOI: 10.1093/carcin/bgaa039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
11 McCord JM, Hybertson BM, Cota-Gomez A, Geraci KP, Gao B. Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19. Antioxidants (Basel) 2020;9:E518. [PMID: 32545518 DOI: 10.3390/antiox9060518] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 24.5] [Reference Citation Analysis]
12 McCord JM, Hybertson BM, Cota-Gomez A, Gao B. Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19. bioRxiv 2020:2020. [PMID: 32511372 DOI: 10.1101/2020.05.16.099788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
13 Patra U, Mukhopadhyay U, Mukherjee A, Sarkar R, Chawla-Sarkar M. Progressive Rotavirus Infection Downregulates Redox-Sensitive Transcription Factor Nrf2 and Nrf2-Driven Transcription Units. Oxid Med Cell Longev 2020;2020:7289120. [PMID: 32322337 DOI: 10.1155/2020/7289120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sarkar R, Patra U, Lo M, Mukherjee A, Biswas A, Chawla-Sarkar M. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics. Cell Microbiol 2020;22:e13149. [PMID: 31845505 DOI: 10.1111/cmi.13149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wyler E, Franke V, Menegatti J, Kocks C, Boltengagen A, Praktiknjo S, Walch-Rückheim B, Bosse J, Rajewsky N, Grässer F, Akalin A, Landthaler M. Single-cell RNA-sequencing of herpes simplex virus 1-infected cells connects NRF2 activation to an antiviral program. Nat Commun 2019;10:4878. [PMID: 31653857 DOI: 10.1038/s41467-019-12894-z] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
16 Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Komoto S, Chawla-Sarkar M. Biphasic regulation of RNA interference during rotavirus infection by modulation of Argonaute2. Cell Microbiol 2019;21:e13101. [PMID: 31424151 DOI: 10.1111/cmi.13101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]